Davidoff Andrew M, Interiano Rodrigo B, Wynn Lynn, Delos Santos Noel, Dome Jeffrey S, Green Daniel M, Brennan Rachel C, McCarville M Beth, Krasin Matthew J, Kieran Kathleen, Williams Mark A
*Department of Surgery, St Jude Children's Research Hospital, Memphis, TN †Department of Surgery, University of Tennessee Health Science Center, Memphis, TN ‡Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN §Department of Oncology, Children's National Medical Center, Washington, DC ¶Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN ||Department of Oncology, St Jude Children's Research Hospital, Memphis, TN **Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, TN ††Department of Urology, University of Iowa Children's Hospital, Iowa City, IA ‡‡Department of Urology, University of Tennessee Health Science Center, Memphis, TN.
Ann Surg. 2015 Oct;262(4):570-6. doi: 10.1097/SLA.0000000000001451.
Wilms tumor is the most common renal cancer in children. Approximately 5% of children with Wilms tumor present with disease in both kidneys. The treatment challenge is to achieve a high cure rate while maintaining long-term renal function. We retrospectively reviewed our institutional experience with nephron sparing surgery (NSS) in patients with synchronous bilateral Wilms tumor (BWT) operated on between 2001 and 2014.
Imaging studies, surgical approach, adjuvant therapy, and pathology reports were reviewed. Outcomes evaluated included surgical complications, tumor recurrence, patient survival, and renal function, as assessed by estimated glomerular filtration rate.
A total of 42 patients with BWT were identified: 39 (92.9%) patients underwent bilateral NSS; only 3 patients (7.1%) underwent unilateral nephrectomy with contralateral NSS. Postoperative complications included prolonged urine leak (10), infection (6), intussusception (2), and transient renal insufficiency (1). Three patients required early (within 4 months) repeat of NSS for residual tumor. In the long-term, 7 (16.7%) patients had local tumor recurrence (managed with repeat NSS in 6 and completion nephrectomy in 1) and 3 had an episode of intestinal obstruction requiring surgical intervention. Overall survival was 85.7% (mean follow-up, 4.1 years). Of the 6 patients who died, 5 had diffuse anaplastic histology. All of the patients had an estimated glomerular filtration rate more than 60 mL/min/1.73 m at the last follow-up; no patient developed end-stage renal disease.
In patients with synchronous, BWT, bilateral NSS is safe and almost always feasible, thereby preserving maximal renal parenchyma. With this approach, survival was excellent, as was maintenance of the renal function.
肾母细胞瘤是儿童最常见的肾癌。约5%的肾母细胞瘤患儿双侧肾脏均患病。治疗的挑战在于在保持长期肾功能的同时实现高治愈率。我们回顾性分析了2001年至2014年间接受手术治疗的双侧同时性肾母细胞瘤(BWT)患者接受保留肾单位手术(NSS)的机构经验。
回顾影像学检查、手术方式、辅助治疗及病理报告。评估的结果包括手术并发症、肿瘤复发、患者生存率及肾功能,肾功能通过估计肾小球滤过率进行评估。
共确定42例BWT患者:39例(92.9%)患者接受了双侧NSS;仅3例(7.1%)患者接受了单侧肾切除术及对侧NSS。术后并发症包括持续性尿漏(10例)、感染(6例)、肠套叠(2例)及短暂性肾功能不全(1例)。3例患者因残留肿瘤需要早期(4个月内)再次进行NSS。长期来看,7例(16.7%)患者出现局部肿瘤复发(6例通过再次NSS治疗,1例通过根治性肾切除术治疗),3例患者发生肠梗阻需要手术干预。总生存率为85.7%(平均随访4.1年)。在6例死亡患者中,5例具有弥漫性间变组织学类型。所有患者在最后一次随访时估计肾小球滤过率均超过60 mL/min/1.73 m²;无患者发展为终末期肾病。
对于双侧同时性BWT患者,双侧NSS安全且几乎总是可行的,从而可保留最大量的肾实质。采用这种方法,生存率良好,肾功能也得以维持。